Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.
Pharmaceutical Market Sizing Methodological framework and country estimations
Pharmaceutical market sizing methodology <ul><li>WHAT  do we estimate?  </li></ul><ul><ul><li>Define product  </li></ul></...
Pharmaceutical market sizing in practice <ul><li>Categories:  </li></ul><ul><ul><li>Drug turnover , based on company data ...
SEE pharma market in 2009 In million  USD 1) Source: Espicom Business Intelligence, The World Pharmaceutical Markets Fact ...
Upcoming SlideShare
Loading in …5
×

Pharmaceutical Market Sizing

4,972 views

Published on

Methodological framework for pharmaceutical market sizing, SEE estimations

Published in: Business, News & Politics
  • Login to see the comments

  • Be the first to like this

Pharmaceutical Market Sizing

  1. 1. Pharmaceutical Market Sizing Methodological framework and country estimations
  2. 2. Pharmaceutical market sizing methodology <ul><li>WHAT do we estimate? </li></ul><ul><ul><li>Define product </li></ul></ul><ul><ul><li>Define level of finalization </li></ul></ul><ul><ul><li>Define measurement </li></ul></ul><ul><li>WHERE do we estimate? </li></ul><ul><ul><li>Global / regional / national / local </li></ul></ul><ul><li>WHEN do we estimate? </li></ul><ul><ul><li>Define frequency (e.g. annually) </li></ul></ul><ul><ul><li>Define period (e.g. for 2010) </li></ul></ul><ul><li>HOW do we estimate? </li></ul><ul><ul><li>Define level of market (by scope of analysis) </li></ul></ul><ul><ul><ul><li>Market Turnover </li></ul></ul></ul><ul><ul><ul><li>Market Consumption </li></ul></ul></ul><ul><ul><ul><li>Market Production </li></ul></ul></ul><ul><ul><li>Define level of market (by supply chain analysis) </li></ul></ul><ul><ul><ul><li>Pharmaceutical market </li></ul></ul></ul><ul><ul><ul><li>Wholesale Market </li></ul></ul></ul><ul><ul><ul><li>Retail Market </li></ul></ul></ul><ul><ul><li>Basic principle: net sales minus (a) non-medicines, (b) internal trade, (c) export, and (d) wholesale/resale </li></ul></ul>MARKET SIZE & MARKET POTENTIAL 4 KEY QUESTIONS: Various data sources (companies, databases, analysis etc)
  3. 3. Pharmaceutical market sizing in practice <ul><li>Categories: </li></ul><ul><ul><li>Drug turnover , based on company data </li></ul></ul><ul><ul><li>Drug consumption , by ATC groups and based on DDD/1000 inhabitants/day methodology </li></ul></ul><ul><li>Parameters: </li></ul><ul><ul><li>Total market size </li></ul></ul><ul><ul><li>Market segments size: </li></ul></ul><ul><ul><ul><li>Rx & OTC drugs </li></ul></ul></ul><ul><ul><ul><li>Generics & Innovative drugs </li></ul></ul></ul><ul><ul><ul><li>Retail & Hospital market, etc. </li></ul></ul></ul><ul><li>Level of the market: </li></ul><ul><ul><li>Pharmaceutical market </li></ul></ul><ul><ul><li>Wholesale market </li></ul></ul><ul><ul><li>Retail market </li></ul></ul><ul><li>General reviews and analysis: </li></ul><ul><ul><li>Pharmaceutical market (total and by segments) </li></ul></ul><ul><ul><li>Wholesale and retail market </li></ul></ul><ul><ul><li>ATC drug consumption </li></ul></ul><ul><ul><li>Top companies </li></ul></ul><ul><ul><li>Other analysis </li></ul></ul>
  4. 4. SEE pharma market in 2009 In million USD 1) Source: Espicom Business Intelligence, The World Pharmaceutical Markets Fact Book 2009 (estimated data, adopted) 2) Source: World Health Organization, World Health Statistics 2010 (actual data) 3) Analysis performed by Aventin Partners All data (except WHO data) are estimated and adopted in order to compare markets 7,6% 8,4% 12% 8,0% 19,5% 2,171 Sub-total / Average n/a 7,0% 13% 0,5% 1,3% 140 Albania n/a 8,9% 12% 0,2% 0,5% 55 Montenegro n/a 7,1% 13% 0,5% 1,1% 125 Macedonia n/a 9,8% 11% 0,8% 1,9% 210 Bosnia and Herzegovina 7,3% 7,6% 10% 3,3% 8,2% 910 Croatia 7,8% 9,9% 13% 2,7% 6,6% 731 Serbia 7,6% 7,7% 10,7% 40,7% 100,0% 11,126 SEE 7,7% 7,0% 9,4% 32,8% 80,5% 8,955 Sub-total / Average 7,6% 7,4% 10% 9,8% 24,0% 2,669 Hungary 9,8% 7,9% 8% 10,9% 26,7% 2,974 Greece 8,5% 7,8% 9% 3,4% 8,3% 923 Slovenia 5,7% 4,7% 12% 6,9% 17,0% 1,886 Romania 6,9% 7,3% 8% 1,8% 4,5% 502 Bulgaria 100,0% % of CEE 245,4% % of SEE n/a HC Expenditures 2007 (% of GDP) 2 10% 2009-2014 CAGR 1 6,0% HC Expenditures 2009 (% of GDP) 1 27,306 CEE Country Pharmaceutical Market Size 2009 1

×